Coronary Artery Bypass Grafts (CABG)

Coronary Artery Bypass Grafts (CABG)

Global Coronary Artery Bypass Grafts (CABG) Market to Reach US$233.0 Million by 2030

The global market for Coronary Artery Bypass Grafts (CABG) estimated at US$170.2 Million in the year 2023, is expected to reach US$233.0 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Off-Pump CABG, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$109.1 Million by the end of the analysis period. Growth in the On-Pump CABG segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$46.0 Million While China is Forecast to Grow at 4.2% CAGR

The Coronary Artery Bypass Grafts (CABG) market in the U.S. is estimated at US$46.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$36.6 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Coronary Artery Bypass Grafts (CABG) Market - Key Trends and Drivers Summarized

When Hearts Rebel: How Modern Life Fuels the Fire of Coronary Heart Disease

Coronary heart disease (CHD) stands as one of the most formidable health challenges of modern civilization, closely linked to contemporary lifestyles characterized by sedentary behavior, poor dietary habits, and high stress. As the leading cause of death globally, CHD epitomizes the lethal consequences of industrialization and urbanization which promote environments detrimental to cardiovascular health. Factors such as increased consumption of processed foods, reduced physical activity, and exposure to pollution have substantially elevated the incidence of this disease, marking it as a critical public health crisis. This condition not only places a significant emotional and financial burden on individuals and families but also exerts immense pressure on healthcare systems worldwide. As societies continue to evolve, addressing the root causes of CHD through public health initiatives, improved lifestyle choices, and access to quality healthcare becomes imperative to alleviate its impact on modern civilization.

How Is Coronary Artery Bypass Grafting Revolutionizing Cardiac Care?

Coronary Artery Bypass Grafting (CABG) is a critical surgical procedure used to improve blood flow to the heart in patients with severe coronary heart disease (CHD). CHD occurs when the coronary arteries become hardened and narrowed due to the buildup of plaque, reducing blood flow to the heart and potentially leading to a heart attack. CABG involves taking a blood vessel from another part of the body and grafting it to the coronary artery above and below the blocked area, thus bypassing the blockage. This allows blood to flow around the obstruction and reach the heart muscle. CABG has proven to be an effective life-saving procedure, particularly for patients with multiple blocked coronary arteries and those who have not responded well to other treatments, offering them a higher quality of life and reduced symptoms of heart disease.

What Advancements Are Shaping CABG Techniques?

Recent advancements in CABG techniques have significantly enhanced the success rates and patient outcomes. One of the major innovations is the development of off-pump coronary artery bypass (OPCAB), which allows surgeons to perform the procedure while the heart is still beating, eliminating the need for a heart-lung machine. This technique reduces complications associated with cardiopulmonary bypass, such as cognitive decline and stroke. Minimally invasive direct coronary artery bypass (MIDCAB) is another advancement that uses smaller incisions rather than opening the chest wall and often involves robotic assistance, which provides greater precision and faster recovery times. These technological advancements have made CABG more accessible and less daunting for patients, significantly reducing postoperative recovery time and improving the overall efficacy of the procedure.

What Challenges Do Patients and Surgeons Face with CABG?

Despite the advancements in CABG techniques, there are still significant challenges that affect both patients and surgeons. One of the main challenges is the risk of complications, which can include infections, kidney failure, and heart attacks during or after surgery. The long-term success of the grafts is also a concern, as they can become narrowed over time, potentially leading to a repeat surgery. From a surgeon`s perspective, the technical complexity of the procedure requires high skill and experience, particularly with newer techniques like OPCAB and MIDCAB, which may not be available in all hospitals. Additionally, the decision-making process regarding the most appropriate surgical approach for each individual patient involves careful consideration of various factors, including the patient’s health status, the severity of artery blockage, and the presence of other medical conditions.

What Drives the Growth in the Coronary Artery Bypass Graft Market?

The growth in the coronary artery bypass graft market is driven by several factors, including an aging global population and an increase in the prevalence of cardiovascular diseases, driven by lifestyle factors such as obesity, smoking, and physical inactivity. Advances in medical imaging technologies have also played a significant role, as they have improved the diagnosis of CHD and the planning of surgical interventions like CABG. Furthermore, the development of newer, more advanced biomaterials for grafts that offer better compatibility and durability is encouraging their increased adoption. Economic growth in emerging markets has led to improved healthcare infrastructure and access to advanced surgical techniques, thereby increasing the number of CABG procedures performed worldwide. Additionally, ongoing clinical research and trials aimed at enhancing the efficacy and safety of CABG contribute to the robust growth of this market. Together, these factors ensure that CABG remains a cornerstone treatment option for coronary heart disease, reflecting its vital role in contemporary cardiac care.

Select Competitors (Total 41 Featured) -
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Coronary Artery Bypass Grafts (CABG) - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Coronary Artery Disease Propels Demand for CABG
Advancements in Minimally Invasive Surgery Techniques Expand Market Reach
Aging Population Globally Drives Need for Effective CABG Procedures
Rising Healthcare Expenditure and Insurance Coverage Bolster CABG Accessibility
Emerging Markets Witness Increased Adoption of Advanced Cardiac Care
Cardiac Rehabilitation Developments Post-CABG Surgery Support Patient Recovery
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Coronary Artery Bypass Grafts (CABG) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
TABLE 5: World Recent Past, Current & Future Analysis for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Off-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for On-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Minimally Invasive Direct by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Saphenous Vein Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Internal Thoracic Artery Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
JAPAN
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
CHINA
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
EUROPE
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
FRANCE
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
GERMANY
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 81: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 82: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 85: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 87: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 88: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 90: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 91: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
TABLE 95: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings